country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-162781

Copy Link Print Information

HDAC1/6-IN-2

HDAC1/6-IN-2 (I-c4) is the inhibitor of HDAC1 and HDAC6, with the IC₅₀s of 3.1 nM and 2.95 nM, respectively. HDAC1/6-IN-2 has antitumor activity.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Formel: C₂₂H₁₇FN₄O₃
Molecular Weight:404.39

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (271 KB)

HDAC1/6-IN-2 Chemical Structure

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- Cellular Effect
Chemical Information
Protokoll (1)
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

HDAC1/6-IN-2 (I-c4) is the inhibitor of HDAC1 and HDAC6, with the IC₅₀s of 3.1 nM and 2.95 nM, respectively. HDAC1/6-IN-2 has antitumor activity^[1].

IC₅₀ & Target

HDAC6

2.95 nM (IC₅₀)

HDAC1

3.1 nM (IC₅₀)

Alle HDAC Isoform-spezifische Produkte anzeigen :

Cellular Effect

Cell Line	Type	Value	Description	References
AGS	IC₅₀	>10 μM Compound: I-c4	Antiproliferative activity against human AGS cells assessed as inhibition of cell growth by MTT assay Antiproliferative activity against human AGS cells assessed as inhibition of cell growth by MTT assay	[PMID: 39102466]
BGC-823	IC₅₀	2.25 μM Compound: I-c4	Antiproliferative activity against human BGC-823 cells assessed as inhibition of cell growth by MTT assay Antiproliferative activity against human BGC-823 cells assessed as inhibition of cell growth by MTT assay	[PMID: 39102466]
HCT-116	IC₅₀	>10 μM Compound: I-c4	Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth by MTT assay Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth by MTT assay	[PMID: 39102466]
HGC-27	IC₅₀	2.8 μM Compound: I-c4	Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell growth by MTT assay Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell growth by MTT assay	[PMID: 39102466]
MGC-803	IC₅₀	0.95 μM Compound: I-c4	Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth by MTT assay Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth by MTT assay	[PMID: 39102466]
MKN-45	IC₅₀	7.43 μM Compound: I-c4	Antiproliferative activity against human MKN-45 cells assessed as inhibition of cell growth by MTT assay Antiproliferative activity against human MKN-45 cells assessed as inhibition of cell growth by MTT assay	[PMID: 39102466]
NCI-H460	IC₅₀	>10 μM Compound: I-c4	Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell growth by MTT assay Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell growth by MTT assay	[PMID: 39102466]
PANC-1	IC₅₀	3.79 μM Compound: I-c4	Antiproliferative activity against human PANC-1 cells assessed as inhibition of cell growth by MTT assay Antiproliferative activity against human PANC-1 cells assessed as inhibition of cell growth by MTT assay	[PMID: 39102466]
PC-3	IC₅₀	>10 μM Compound: I-c4	Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth by MTT assay Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth by MTT assay	[PMID: 39102466]
SGC-7901	IC₅₀	8.34 μM Compound: I-c4	Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell growth by MTT assay Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell growth by MTT assay	[PMID: 39102466]
SMMC-7721	IC₅₀	2.74 μM Compound: I-c4	Antiproliferative activity against human SMMC-7721 cells assessed as inhibition of cell growth by MTT assay Antiproliferative activity against human SMMC-7721 cells assessed as inhibition of cell growth by MTT assay	[PMID: 39102466]
TE-1	IC₅₀	4.5 μM Compound: I-c4	Antiproliferative activity against human TE-1 cells assessed as inhibition of cell growth by MTT assay Antiproliferative activity against human TE-1 cells assessed as inhibition of cell growth by MTT assay	[PMID: 39102466]

Chemical Information

Molecular Weight 404.39
Formel C₂₂H₁₇FN₄O₃
SMILES

O=C(C1=CC(C2=CC=C(C=C2)F)=CN3C1=NC=C3)NCC4=CC=C(C=C4)C(NO)=O
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Protokoll

All Animals and Diseases

Subcutaneous Cell-Line-Derived Xenograft
Subcutaneous cell-line-derived xenograft (CDX) models are established by implanting cultured human cancer cell lines into immunodeficient mice, where the injected cells form localized tumors that can be monitored in vivo as a measure of tumorigenic potential, growth kinetics, and treatment response. These models are widely used in oncology research because they allow reproducible tumor formation and enable comparative assessment of tumor growth between different cell lines or genetic manipulations in a controlled in vivo microenvironment. Subcutaneous implantation of cancer cells in immunodeficient mice is a standard approach for evaluating tumor growth behavior and therapeutic response across multiple cancer types, including prostate, esophageal, pancreatic, and colon cancer models.

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (271 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Fei-Fei Yang, et al. Discovery of Novel Imidazo[1,2-a]pyridine-Based HDAC6 Inhibitors as an Anticarcinogen with a Cardioprotective Effect. J Med Chem. 2024 Aug 22;67(16):14345-14369. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen